{"schema_version":"1","generated_at":"2026-10-28T09:31:48.072Z","data_as_of":null,"url":"https://www.findmykol.com/kol/daniel-shu","json_url":"https://www.findmykol.com/kol/daniel-shu/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"daniel-shu","name":"Daniel Shu","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Maryland, Baltimore","institution_url":"https://www.findmykol.com/institution/university-of-maryland-baltimore","city":"Baltimore","state":"MD","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1790216414","orcid":"0000-0003-1348-5556","openalex":"A5024888979"},"summary":"Daniel Shu is an Oncology physician affiliated with University of Maryland, Baltimore. OpenAlex indexes 55 publications with 791 citations (h-index 11); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":55,"cited_by_count":791,"h_index":11,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00419263","title":"Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"BioCryst Pharmaceuticals","source_url":"https://clinicaltrials.gov/study/NCT00419263","trial_url":"https://www.findmykol.com/trial/NCT00419263"}],"source":"trials"},"payments":{"company_count":7,"program_years":{"first":2021,"last":null},"rows_total":7,"shown":3,"withheld":4,"rows":[{"payer":"Astellas Pharma US Inc","program_year":2025,"amount_usd":57.21,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1790216414"},{"payer":"TerSera Therapeutics LLC","program_year":2025,"amount_usd":36.09,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1790216414"},{"payer":"Merck Sharp & Dohme LLC","program_year":2025,"amount_usd":31.72,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1790216414"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1790216414","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitors","year":2025,"journal":"Nature Communications","source_url":"https://doi.org/10.1038/s41467-025-58512-z","status":"verified"},{"title":"Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair–Proficient Colorectal Cancer","year":2025,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1078-0432.ccr-25-0002","status":"verified"},{"title":"Deep immune profiling of intrahepatic cholangiocarcinoma with CODEX multiplexed imaging","year":2025,"journal":"Hepatology Communications","source_url":"https://doi.org/10.1097/hc9.0000000000000632","status":"verified"},{"title":"More than the sum: How vascular endothelial growth factor inhibition unlocks the full potential of immune checkpoint blockade","year":2025,"journal":"Immunity","source_url":"https://doi.org/10.1016/j.immuni.2025.03.009","status":"verified"},{"title":"Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial","year":2024,"journal":"Nature Medicine","source_url":"https://doi.org/10.1038/s41591-024-02894-y","status":"verified"}],"source":"works"},"contact":{"address_1":"1800 ORLEANS ST","address_2":"THE JOHNS HOPKINS HOSPITAL","city":"Baltimore","state":"MD","zip":"212870010","phone":"410-955-7911","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1790216414","source":"identity"},"similar":[{"name":"Gloria Reeves","slug":"gloria-reeves","institution":"University of Maryland, Baltimore","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/gloria-reeves","json_url":"https://www.findmykol.com/kol/gloria-reeves/profile.json"},{"name":"Karen Kotloff","slug":"karen-kotloff","institution":"University of Maryland, Baltimore","specialty":"Pediatric Infectious Diseases","url":"https://www.findmykol.com/kol/karen-kotloff","json_url":"https://www.findmykol.com/kol/karen-kotloff/profile.json"},{"name":"Christopher Plowe","slug":"christopher-plowe","institution":"University of Maryland, Baltimore","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/christopher-plowe","json_url":"https://www.findmykol.com/kol/christopher-plowe/profile.json"},{"name":"Michael Domanski","slug":"michael-domanski","institution":"University of Maryland, Baltimore","specialty":"Advanced Heart Failure and Transplant Cardiology","url":"https://www.findmykol.com/kol/michael-domanski","json_url":"https://www.findmykol.com/kol/michael-domanski/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":4,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-03-15","provider_certified":"2024-03-15","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}